logo-large
  • Browse Categories

Publications by authors named "Ali Kalem"

Claim this Profile
C
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG).
Ali Kalem, Tulay Kus, Savas Gokcek, Ilkay Tugba Unek, Taha Koray Sahin

J Clin Med· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG).
Ali Kalem, Tulay Kus, Taha Koray Sahin, Omer Dizdar, Safa Can Efil

Cancers (Basel)· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.
Sedat Yıldırım, Tugba Başoğlu, Akif Doğan, Goncagul Akdağ, Oguzcan Kınıkoğlu, Ali Kalem

BMC Cancer· May 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isotretinoin-induced Spondyloarthropathy-related Symptoms: A Prospective Study.
Samet Alkan, Nuriye Kayiran, Orhan Zengin, Ali Kalem, Gezmis Kimyon

J Rheumatol· November 2015


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: